3-Chloro-3-(3-methoxyphenyl)acrylonitrile | 1055176-04-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-Chloro-3-(3-methoxyphenyl)acrylonitrile
• 英文别名: (Z)-3-chloro-3-(3-methoxyphenyl)prop-2-enenitrile
• CAS: 1055176-04-9
• 化学式: C₁₀H₈ClNO
• 分子量: 193.633
• InChiKey: ZFWKAJKWKITFMM-YHYXMXQVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Chloro-3-(3-methoxyphenyl)acrylonitrile 在 sodium hydroxide 、 sodium methylate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 36.0h， 生成 5-(3-Methoxy-phenyl)-3-(oxalyl-amino)-thiophene-2-carboxylic acid
  参考文献：
  名称：

  Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B

  摘要：

  Reversible phosphorylation and dephosphorylation of key proteins on tyrosine residues are important parts of intracellular signaling triggered by hormones and other agents. Recent knock-out studies in mice have identified PTP1B as a potential target for the treatment of diabetes and obesity. As a consequence, a number of academic and industrial groups are aggressively pursuing the development of selective PTP1B inhibitors. In addition, other protein-tyrosine phosphatases (PTPs) appear to be critically involved in major diseases such as cancer and autoimmunity. Given the diversity of PTPs and their potential as drug targets in different diseases, we have taken a broad approach to develop active site-directed selective inhibitors of specific members of this family of enzymes. Using a high throughput screening, we have previously identified 2-(oxalylamino)benzoic acid 3a as a relatively weak but classical competitive inhibitor of several PTPs.(4) On the basis of our early studies, indicating that 3a might be used as a starting point for the synthesis of selective PTP inhibitors, we now present our efforts in expansion of this concept and provide here a number of new chemical scaffolds for the development of inhibitors of different members of the PTP family. Although the core structure of these inhibitors is charged, good oral bioavailability has been observed in rat for some compounds. Furthermore, we have observed enhancement of 2-deoxy-glucose accumulation in C2C12 cells with prodrug analogues.

  DOI：

  10.1021/jm0209026
• 作为产物：
  描述：

  N,N-二甲基甲酰胺 、 3-甲氧基苯乙酮 在 三氯氧磷 、 盐酸羟胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 3-Chloro-3-(3-methoxyphenyl)acrylonitrile
  参考文献：
  名称：

  新型微管蛋白抑制剂2-（3'，4'，5'-三甲氧基苯甲酰基）-3-氨基5-芳基噻吩的合成及生物学评价。

  摘要：

  合成2-（3'，4'，5'-三甲氧基苯甲酰基）-3-氨基-5-芳基/杂芳基噻吩衍生物并评估其抗增殖活性，抑制微管蛋白聚合和细胞周期效应。用噻吩基环的芳基部分5-位上的各种取代基阐明了SAR。5-苯基对位的取代基显示出抗增殖活性，顺序为F = CH（3）> OCH（3）= Br = NO（2）> CF（3）= I> OEt。这些化合物中的几种导致HL-60细胞停滞在细胞周期的G2 / M期并诱导凋亡。

  DOI：

  10.1021/jm060804a

文献信息

• HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
  申请人：Pharmacia Corporation

  公开号：EP1444010A2

  公开（公告）日：2004-08-11
• [EN] HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION<br/>[FR] DERIVES DE CARBOXAMIDE HETEROAROMATIQUE DESTINES AU TRAITEMENT DES INFLAMMATIONS
  申请人：PHARMACIA CORP

  公开号：WO2003037886A2

  公开（公告）日：2003-05-08

  The present invention relates to heteroaromatic carboxamide derivatives, compositions comprising such, intermediates, methods of making heteroaromatic carboxamide derivatives, and methods for treating cancer, inflammation, and inflammation-associated disorders, such as arthritis.
• Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B
  作者：Henrik Sune Andersen、Ole H. Olsen、Lars F. Iversen、Anette L. P. Sørensen、Steen B. Mortensen、Michael S. Christensen、Sven Branner、Thomas K. Hansen、Jesper F. Lau、Lone Jeppesen、Edmond J. Moran、Jing Su、Farid Bakir、Luke Judge、Manou Shahbaz、Tassie Collins、Todd Vo、Michael J. Newman、William C. Ripka、Niels Peter H. Møller

  DOI：10.1021/jm0209026

  日期：2002.9.1

  Reversible phosphorylation and dephosphorylation of key proteins on tyrosine residues are important parts of intracellular signaling triggered by hormones and other agents. Recent knock-out studies in mice have identified PTP1B as a potential target for the treatment of diabetes and obesity. As a consequence, a number of academic and industrial groups are aggressively pursuing the development of selective PTP1B inhibitors. In addition, other protein-tyrosine phosphatases (PTPs) appear to be critically involved in major diseases such as cancer and autoimmunity. Given the diversity of PTPs and their potential as drug targets in different diseases, we have taken a broad approach to develop active site-directed selective inhibitors of specific members of this family of enzymes. Using a high throughput screening, we have previously identified 2-(oxalylamino)benzoic acid 3a as a relatively weak but classical competitive inhibitor of several PTPs.(4) On the basis of our early studies, indicating that 3a might be used as a starting point for the synthesis of selective PTP inhibitors, we now present our efforts in expansion of this concept and provide here a number of new chemical scaffolds for the development of inhibitors of different members of the PTP family. Although the core structure of these inhibitors is charged, good oral bioavailability has been observed in rat for some compounds. Furthermore, we have observed enhancement of 2-deoxy-glucose accumulation in C2C12 cells with prodrug analogues.
• Synthesis and Biological Evaluation of 2-(3‘,4‘,5‘-Trimethoxybenzoyl)-3-Amino 5-Aryl Thiophenes as a New Class of Tubulin Inhibitors
  作者：Romeo Romagnoli、Pier Giovanni Baraldi、Vincent Remusat、Maria Dora Carrion、Carlota Lopez Cara、Delia Preti、Francesca Fruttarolo、Maria Giovanna Pavani、Mojgan Aghazadeh Tabrizi、Manlio Tolomeo、Stefania Grimaudo、Jan Balzarini、Mary Ann Jordan、Ernest Hamel

  DOI：10.1021/jm060804a

  日期：2006.10.1

  2-(3',4',5'-Trimethoxybenzoyl)-3-amino-5-aryl/heteroaryl thiophene derivatives were synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. SARs were elucidated with various substitutions on the aryl moiety 5-position of the thienyl ring. Substituents at the para-position of the 5-phenyl group showed antiproliferative activity in the order

  合成2-（3'，4'，5'-三甲氧基苯甲酰基）-3-氨基-5-芳基/杂芳基噻吩衍生物并评估其抗增殖活性，抑制微管蛋白聚合和细胞周期效应。用噻吩基环的芳基部分5-位上的各种取代基阐明了SAR。5-苯基对位的取代基显示出抗增殖活性，顺序为F = CH（3）> OCH（3）= Br = NO（2）> CF（3）= I> OEt。这些化合物中的几种导致HL-60细胞停滞在细胞周期的G2 / M期并诱导凋亡。